Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort
Pierre‐Jean Saulnier(Inserm), Samy Hadjadj(Université de Poitiers), Stéphanie Ragot(Université de Tours), Elise Gand(Université de Poitiers), Kamel Mohammedi(Hôpital Cardiologique du Haut-Lévêque), M. Fraty(Centre Hospitalier Universitaire de Poitiers), Gilberto Velho(Inserm), Ronan Roussel(Lyon 1 Université), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Philippe Zaoui(Centre Hospitalier Universitaire de Grenoble)
Cited by 61
Related Papers
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
|The Lancet Diabetes & Endocrinology|2017|295
Effect of a diabetic environment in utero on predisposition to type 2 diabetes
|The Lancet|2003|286
Adult Faconi Syndrome Secondary to Light Chain Gammopathy: Clinicopathologic Heterogeneity and Unnsual Features in 11 Patients
|Medicine|2000|229
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228